1282
C. Lorenc et al. / Tetrahedron Letters 56 (2015) 1280–1282
O
O
MsOH, anisole (1:1 v/v)
N
N
H
+
+
90 °C, 5 h
3
4
OMe
OMe
26
27
Scheme 3. Trapping of the isopropyl cation with anisole.
N-phenyladamantane-1-carboxamide (12):12 white solid; 1H NMR (400 MHz,
CDCl3) d 7.55–7.53 (m, 2H), 7.38–7.28 (m, 3H), 7.10–7.06 (m, 1H), 2.12–2.06
(m, 3H), 1.96 (d, J = 2.6 Hz, 6H), 1.79–1.71 (m, 6H); 13C NMR (100 MHz, CDCl3) d
176.1, 138.1, 128.9, 124.1, 120.0, 41.5, 39.3, 36.5, 28.2; LC–MS (m/z) [M+H]+:
256 (C17H22NO: 256.17).
References and notes
N-cyclohexyladamantane-1-carboxamide (14):13 white solid; 1H NMR (400 MHz,
CDCl3) d 5.42 (br s, 1H), 3.82–3.70 (m, 1H), 2.06–2.00 (m, 3H), 1.92–1.81
(m, 8H), 1.77–1.65 (m, 8H), 1.64–1.57 (m, 1H), 1.43–1.31 (m, 2H), 1.23–1.04
(m, 3H); 13C NMR (100 MHz, CDCl3) d 176.9, 47.6, 40.4, 39.3, 36.6, 33.2, 28.2,
25.6, 24.9; LC–MS (m/z) [M+H]+: 262 (C17H28NO: 262.22).
N-isopropylcyclohexanecarboxamide (16):14 white solid; 1H NMR (400 MHz,
CDCl3) d 5.32 (br s, 1H), 4.03–4.07 (m, 1H), 2.02–1.97 (m, 1H), 1.89–1.05 (m,
10H), 1.12 (d, J = 6.5 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 175.1, 45.6, 41.0,
29.7, 25.7, 22.8; LC–MS (m/z) [M+H]+: 170 (C10H20NO: 170.15).
N-isopropyldecanamide (18):15 white solid; 1H NMR (400 MHz, CDCl3) d 5.93–
5.91 (br, 1H), 4.05–3.93 (m, 1H), 2.05 (t, J = 7.4 Hz, 2H), 1.57–1.49 (m, 2H),
1.21–1.15 (m, 12H), 1.06 (d, J = 6.6 Hz, 6H), 0.80 (m, 3H); 13C NMR (100 MHz,
CDCl3) d 172.3, 41.0, 36.8, 31.8, 29.4, 29.3, 29.26, 29.21, 25.9, 22.6, 13.9; LC–MS
(m/z) [M+H]+: 214 (C13H28NO: 214.22).
N-isopropylbenzamide (20):16 tan solid; 1H NMR (400 MHz, CDCl3)
d 7.75
(d, J = 8.3 Hz, 2H), 7.47–7.37 (m, 3H), 6.10 (br s, 1H), 4.34–4.22 (m, 1H), 1.24
(d, J = 6.4 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 166.8, 134.9, 131.2, 128.3,
126.8, 41.8, 22.7; LC–MS (m/z) [M+H]+: 164 (C10H14NO: 164.11).
N-isopropyl-4-methoxybenzamide (22):17 white solid; 1H NMR (400 MHz, CDCl3)
d 7.72 (d, J = 8.9 Hz, 2H), 6.89 (d, J = 8.9 Hz, 2H), 5.95 (br s, 1H), 4.31–4.23 (m,
1H), 3.82 (s, 3H), 1.25 (d, J = 6.7 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 165.5,
161.2, 128.0, 126.6, 113.0, 54.6, 41.1, 22.2; LC–MS (m/z) [M+H]+: 194
(C11H16NO2: 194.12).
8. General procedure for N-isopropyl amide deprotection with MsOH.
N-isopropyladamantane-1-carboxamide (4):9
A round bottomed flask was
charged with amide 3 (400 mg, 1.52 mmol) and methanesulfonic acid (10 vol-
umes, 4.00 mL). The mixture was heated at 90 °C under nitrogen until complete
consumption of starting material was observed by LC–MS and TLC analysis (see
Table 1 for specific reaction times). The reaction mixture was cooled to rt,
diluted with CH2Cl2, and the solution was washed with water twice, dried over
Na2SO4, filtered, and concentrated. The crude product was purified by
chromatography on SiO2 using hexanes/EtOAc to give 4 (308 mg, 92% yield)
as an off-white solid. 1H NMR (400 MHz, CDCl3) d 5.36 (br s, 1H), 4.12–4.00 (m,
1H), 2.06–2.01 (m, 3H), 1.83 (d, J = 2.6 Hz, 6H), 1.76–1.67 (m, 6H), 1.13 (d,
J = 6.5 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 177.0, 40.8, 40.4, 39.3, 36.6, 28.2,
22.8; LC–MS (m/z) [M+H]+: 222 (C14H24NO: 222.19).
N-isopropyl-4-nitrobenzamide (24):17 tan solid; 1H NMR (400 MHz, CDCl3) d
8.28 (d, J = 9.0 Hz, 2H), 7.93 (d, J = 9.0 Hz, 2H), 6.01 (br s, 1H), 4.34–4.28 (m,
1H), 1.29 (d, J = 6.7 Hz, 6H); 13C NMR (100 MHz, CDCl3) d 165.2, 150.0, 141.0,
128.6, 124.6, 43.0, 23.2; LC–MS (m/z) [M+H]+: 209 (C10H13N2O3: 209.09).
N-ethyladamantane-1-carboxamide (6):10 white solid; 1H NMR (400 MHz,
CDCl3) d 5.59 (br s, 1H), 3.31–3.24 (m, 2H), 2.04 (br s, 3H), 1.85 (br s, 6H),
1.76–1.68 (m, 6H), 1.13 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) d 177.8,
40.5, 39.3, 36.6, 34.1, 28.2, 14.9; LC–MS (m/z) [M+H]+: 208 (C13H22NO: 208.17).
N-methyladamantane-1-carboxamide (8):11 white solid; 1H NMR (400 MHz,
CDCl3) d 5.60 (br s, 1H), 2.80 (d, J = 4.6 Hz, 3H), 2.07–2.01 (m, 3H), 1.85 (d,
J = 2.7 Hz, 6H), 1.78–1.66 (m, 6H); 13C NMR (100 MHz, CDCl3) d 178.6, 40.6,
39.3, 36.6, 28.1, 26.3; LC–MS (m/z) [M+H]+: 194 (C12H20NO: 194.15).